Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides

被引:167
作者
Agrawal, S [1 ]
机构
[1] Hybridon Inc, Milford, MA 01757 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 1999年 / 1489卷 / 01期
关键词
antisense; oligonucleotide; mixed-backbone oligonucleotide; pharmacokinetics; immune stimulation; CpG; pro-drug; antiviral;
D O I
10.1016/S0167-4781(99)00141-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The antisense approach is conceptually simple and elegant; to design an inhibitor of a specific mRNA, one needs only to know the sequence of the targeted mRNA and an appropriately modified complementary oligonucleotide. Of the many analogs of oligodeoxynucleotides explored as antisense agents, phosphorothioate analogs have been studied the most extensively. The use of phosphorothioate oligodeoxynucleotides as antisense agents in various studies have shown promising results. However, they have also indicated that quite often, biological effects observed could be solely or partly non-specific in nature. It is becoming clear that not all phosphorothioate oligodeoxynucleotides of varying length and base composition are the same, and important consideration should be given to maintain antisense mechanisms while identifying effective antisense oligonucleotides. In this review, I have summarized the progress made in my laboratory in understanding the specificity and mechanism of actions of phosphorothioate oligonucleotides and the rationale for designing second-generation mixed-backbone oligonucleotides. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:53 / 68
页数:16
相关论文
共 111 条
[1]  
Agrawal S, 1998, HANDB EXP PHARM, V131, P525
[2]   PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J].
AGRAWAL, S ;
TEMSAMANI, J ;
TANG, JY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7595-7599
[3]   Effect of G-rich sequences on the synthesis, purification, hybridization, cell uptake, and hemolytic activity of oligonucleotides [J].
Agrawal, S ;
Iadarola, PL ;
Temsamani, J ;
Zhao, QY ;
Shaw, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) :2219-2224
[4]   SYNTHESIS AND ANTI-HIV ACTIVITY OF OLIGORIBONUCLEOTIDES AND THEIR PHOSPHOROTHIOATE ANALOGS [J].
AGRAWAL, S ;
TANG, JY ;
SUN, D ;
SARIN, PS ;
ZAMECNIK, PC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 660 :2-10
[5]   INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS IN EARLY INFECTED AND CHRONICALLY INFECTED-CELLS BY ANTISENSE OLIGODEOXYNUCLEOTIDES AND THEIR PHOSPHOROTHIOATE ANALOGS [J].
AGRAWAL, S ;
IKEUCHI, T ;
SUN, D ;
SARIN, PS ;
KONOPKA, A ;
MAIZEL, J ;
ZAMECNIK, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7790-7794
[6]   SITE-SPECIFIC EXCISION FROM RNA BY RNASE-H AND MIXED-PHOSPHATE-BACKBONE OLIGODEOXYNUCLEOTIDES [J].
AGRAWAL, S ;
MAYRAND, SH ;
ZAMECNIK, PC ;
PEDERSON, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1401-1405
[7]   In vivo pharmacokinetics of phosphorothioate oligonucleotides containing contiguous guanosines [J].
Agrawal, S ;
Tan, WT ;
Cai, QY ;
Xie, XW ;
Zhang, RW .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (03) :245-249
[8]   Effect of aspirin on protein binding and tissue disposition of oligonucleotide phosphorothioate in rats [J].
Agrawal, S ;
Zhang, XS ;
Cai, QY ;
Kandimalla, ER ;
Manning, A ;
Jiang, ZW ;
Marcel, T ;
Zhang, RW .
JOURNAL OF DRUG TARGETING, 1998, 5 (04) :303-312
[9]   Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats [J].
Agrawal, S ;
Zhao, QY ;
Jiang, ZW ;
Oliver, C ;
Giles, H ;
Heath, J ;
Serota, D .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (06) :575-584
[10]   ANTISENSE OLIGONUCLEOTIDES AS ANTIVIRAL AGENTS [J].
AGRAWAL, S .
TRENDS IN BIOTECHNOLOGY, 1992, 10 (05) :152-158